论文部分内容阅读
目的观察小儿肺热咳喘口服液的临床疗效和安全性。方法将200例患儿随机分为两组,均予常规抗感染、补液等对症治疗,治疗组100例应用小儿肺热咳喘口服液;对照组100例用盐酸氨溴索口服液,疗程5d,观察两组患儿治疗前后症状改善情况。结果两组总有效率差异无统计学意义,但显效率差异有统计学意义(P<0.05);治疗组在退热、改善鼻塞流涕等方面优于对照组(P<0.05),在止咳、祛痰、消除啰音方面与对照组比较差异无统计学意义(P>0.05)。两组不良反应少且轻微。结论小儿肺热咳喘口服液是一种安全有效的止咳化痰药,可有效地提高治愈率和缩短疗程。
Objective To observe the clinical efficacy and safety of Hyperactivity Kechuan oral liquid in children. Methods 200 cases of children were randomly divided into two groups, were routine anti-infective, fluid replacement symptomatic treatment, the treatment group of 100 cases of Hyperactivity Kechuan oral solution; control group of 100 cases with ambroxol hydrochloride oral solution, the treatment of 5d , To observe the two groups of children before and after treatment to improve the symptoms. Results There was no significant difference in the total effective rate between the two groups (P <0.05), but the difference was statistically significant (P <0.05). The treatment group was superior to the control group in relieving fever and improving nasal obstruction and runny nose (P <0.05) , Expectorant, eliminate rales compared with the control group, the difference was not statistically significant (P> 0.05). Two groups of adverse reactions and minor. Conclusion Hyperactivity Kechuan oral liquid is a safe and effective cough and phlegm medicine, which can effectively improve the cure rate and shorten the course of treatment.